Company profile: Foldax
1.1 - Company Overview
Company description
- Provider of synthetic heart valve solutions delivering non-thrombogenic aortic and mitral valves at lower cost, including TRIA surgical and TAVR valves with computer-designed frames and leaflets to match natural function; LifePolymer non-animal polymer offering biostability, biocompatibility and resistance to calcification; automated robotic manufacturing, FEA design, and polymer applications in medical and industrial devices.
Products and services
- LifePolymer™: Medical-grade, non-animal polymer formulated for heart valves, delivering biostability, biocompatibility, and resistance to calcification and degradation, with applications in insulin pumps, catheters, drug delivery, electronics, and antifouling coatings
- TRIA™ Surgical and Transcatheter Replacement (TAVR) Valves: Custom-engineered heart valves for surgical and transcatheter implantation, using computer-designed frames and leaflets to emulate natural function in non-thrombogenic aortic and mitral positions
- Automated Robotic Manufacturing: Industrial-grade process deploying robotics to fabricate heart valves with high precision and minimal human handling, automating production to reduce manual touchpoints
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Foldax
Carmeda
HQ: Sweden
Website
- Description: Provider of hemocompatible surface coating for medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmeda company profile →
CardioDynamics
HQ: United States
Website
- Description: Provider of noninvasive impedance cardiography diagnostic and monitoring devices and proprietary ICG sensors, including BioZ Dx, BioZ ICG Monitor, BioZ ICG Module, BioZtect sensors, Niccomo and Cardioscreen monitor, and Rheoscreen measurement devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioDynamics company profile →
HeartHero
HQ: United States
Website
- Description: Provider of portable automated external defibrillator technology and companion mobile app. HeartHero's Elliot AED is designed for non-medical users and offers audio/visual prompts, multilingual support, and connectivity for remote monitoring and post-event data access. The HeartHero App connects to the AED to monitor device status, manage settings, access training videos, and order replacement supplies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartHero company profile →
AMT Medical
HQ: The Netherlands
Website
- Description: Provider of a minimally invasive medical device for heart bypass surgery. Its AMT Heart Bypass System, based on ELANA bypass technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and the UMCU research team, is designed to make traditional heart bypass procedures faster, safer, and easier.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMT Medical company profile →
Ancora Heart
HQ: United States
Website
- Description: Provider of the AccuCinch Ventricular Restoration System, a minimally invasive therapy for heart failure patients with reduced ejection fraction, aiming to reduce the size of the left ventricle and support its wall, and the CORCINCH-HF clinical study evaluating the safety and efficacy of AccuCinch in patients with symptomatic heart failure and reduced ejection fraction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ancora Heart company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Foldax
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Foldax
2.2 - Growth funds investing in similar companies to Foldax
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Foldax
4.2 - Public trading comparable groups for Foldax
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →